Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Effectiveness of the Alma System in Treating Primary Postpartum Hemorrhage

NCT06166771 is registered in ClinicalTrials.gov with ResQ Medical Ltd as lead sponsor.

NCT NCT06166771
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06166771 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Effectiveness of the Alma System in Treating Primary Postpartum Hemorrhage
Lead sponsor
ResQ Medical Ltd
Phase
Not applicable
Overall status
Unknown status
Start date
September 9, 2024
Completion date
June 30, 2025
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

postpartum hemorrhage \(pph\), postpartum hemorrhage \(primary\), pph